| Primary |
| Rheumatoid Arthritis |
85.6% |
| Hypertension |
1.8% |
| Polyarthritis |
1.8% |
| Prophylaxis |
1.7% |
| Osteoporosis |
1.5% |
| Juvenile Arthritis |
1.1% |
| Pain |
1.0% |
| Premedication |
0.7% |
| Psoriatic Arthropathy |
0.6% |
| Arthritis |
0.6% |
| Migraine |
0.6% |
| Prophylaxis Against Gastrointestinal Ulcer |
0.5% |
| Gastritis Prophylaxis |
0.4% |
| Depression |
0.4% |
| Gastritis |
0.4% |
| Insomnia |
0.3% |
| Glaucoma |
0.3% |
| Hyperlipidaemia |
0.3% |
| Angina Pectoris |
0.3% |
| Musculoskeletal Pain |
0.3% |
|
| Drug Ineffective |
25.4% |
| Rash |
5.6% |
| Nausea |
5.3% |
| Rheumatoid Arthritis |
5.3% |
| Circumstance Or Information Capable Of Leading To Medication Error |
4.7% |
| Headache |
4.4% |
| Vomiting |
4.2% |
| Pain |
4.2% |
| Urticaria |
4.1% |
| Medication Error |
3.8% |
| Death |
3.7% |
| Pneumonia |
3.7% |
| Fatigue |
3.6% |
| Adverse Event |
3.5% |
| Pyrexia |
3.4% |
| Urinary Tract Infection |
3.4% |
| Weight Decreased |
3.2% |
| Incorrect Storage Of Drug |
2.9% |
| Interstitial Lung Disease |
2.8% |
| Sinusitis |
2.7% |
|
| Secondary |
| Rheumatoid Arthritis |
77.1% |
| Product Used For Unknown Indication |
9.7% |
| Polyarthritis |
1.4% |
| Psoriatic Arthropathy |
1.4% |
| Drug Use For Unknown Indication |
1.1% |
| Juvenile Arthritis |
1.1% |
| Migraine |
1.1% |
| Osteoporosis |
1.0% |
| Crohn's Disease |
1.0% |
| Hypertension |
1.0% |
| Vasculitis |
0.9% |
| Menopausal Symptoms |
0.7% |
| Arthritis |
0.5% |
| Systemic Lupus Erythematosus |
0.4% |
| Antifungal Prophylaxis |
0.3% |
| Atypical Mycobacterial Infection |
0.3% |
| Deep Vein Thrombosis |
0.3% |
| Depression |
0.3% |
| Diabetes Mellitus |
0.3% |
| Hiatus Hernia |
0.3% |
|
| Uterine Carcinoma In Situ |
29.7% |
| Breast Cancer Stage Iv |
9.4% |
| Weight Decreased |
7.5% |
| Drug Ineffective |
6.6% |
| Vomiting |
6.6% |
| Vasculitis |
5.2% |
| Pneumonia |
3.8% |
| Urticaria |
3.3% |
| Blood Pressure Increased |
2.8% |
| Bone Fissure |
2.8% |
| Metastases To Spine |
2.8% |
| Rheumatoid Arthritis |
2.8% |
| Breast Cancer Metastatic |
2.4% |
| Nausea |
2.4% |
| Red Blood Cell Count Decreased |
2.4% |
| Acute Myeloid Leukaemia |
1.9% |
| Cellulitis |
1.9% |
| Drug Hypersensitivity |
1.9% |
| Joint Swelling |
1.9% |
| Local Swelling |
1.9% |
|
| Concomitant |
| Rheumatoid Arthritis |
47.1% |
| Product Used For Unknown Indication |
19.9% |
| Drug Use For Unknown Indication |
9.6% |
| Osteoporosis |
4.7% |
| Pain |
2.6% |
| Psoriatic Arthropathy |
2.1% |
| Hypertension |
1.9% |
| Arthritis |
1.8% |
| Psoriasis |
1.7% |
| Fibromyalgia |
1.3% |
| Gastrooesophageal Reflux Disease |
0.9% |
| Nausea |
0.9% |
| Vitamin Supplementation |
0.8% |
| Angina Pectoris |
0.7% |
| Juvenile Arthritis |
0.7% |
| Arthralgia |
0.6% |
| Depression |
0.6% |
| Insomnia |
0.6% |
| Premedication |
0.6% |
| Radiculopathy |
0.6% |
|
| Drug Ineffective |
21.8% |
| Rheumatoid Arthritis |
14.8% |
| Therapeutic Response Decreased |
10.3% |
| Pain In Extremity |
6.3% |
| Urticaria |
5.5% |
| Vomiting |
5.2% |
| Weight Decreased |
4.1% |
| Pain |
3.7% |
| Malaise |
3.0% |
| Injection Site Pain |
2.6% |
| Joint Swelling |
2.6% |
| Swelling |
2.6% |
| Urinary Tract Infection |
2.6% |
| Bile Duct Cancer |
2.2% |
| Colitis Ischaemic |
2.2% |
| Facial Palsy |
2.2% |
| Pneumonia |
2.2% |
| Rash |
2.2% |
| Sinusitis |
2.2% |
| Drug Effect Decreased |
1.8% |
|
| Interacting |
| Crohn's Disease |
52.7% |
| Rheumatoid Arthritis |
25.5% |
| Nervous System Disorder |
7.3% |
| Psychomotor Hyperactivity |
7.3% |
| Parkinson's Disease |
3.6% |
| Bacterial Infection |
1.8% |
| Multiple Sclerosis |
1.8% |
|
| Drug Interaction |
40.0% |
| Dyskinesia |
20.0% |
| Pruritus Generalised |
13.3% |
| Salivary Hypersecretion |
13.3% |
| Stomatitis |
6.7% |
| Tremor |
6.7% |
|
